Wu Ding Wen, Friedman Mark T, Lombardi Daniel P, Hwang Richard, Sender Joel, Cobaj Valdet, Niazi Masooma, Li Yanhua, Karpinos Robert
Department of Pathology, SBH Health System, Bronx, NY 10457, USA.
Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA.
Life (Basel). 2024 Feb 7;14(2):232. doi: 10.3390/life14020232.
This study aimed to showcase how implementing a patient blood management (PBM) program effectively cuts unnecessary red blood cell (RBC) transfusions in a New York City urban community teaching hospital.
Analyzing seven years from 2013 to 2019, a retrospective review of RBC transfusions was conducted.
Following the introduction of PBM, considerable improvements were observed annually. These included a drop in mean pretransfusion hemoglobin levels from 7.26 g/dL (2013) to 6.58 g/dL (2019), a 34% reduction in yearly RBC unit transfusions, and fewer units given to patients with pre-Hgb levels ≥ 7 g/dL (from 1210 units in 2013 to 310 units in 2019). Furthermore, this study noted a decline in two-unit RBC orders when Hgb levels were ≥ 7 g/dL from 65 orders in 2013 to merely 3 in 2019. The estimated total cost savings attributed to the six-year PBM program duration after full implementation in 2014 amounted to USD 2.1 million.
Overall, PBM implementation significantly decreased RBC transfusions and enhanced transfusion practices. The findings emphasize that successful PBM strategies do not always necessitate extensive resources or increased budgets but instead rely on the application of intuitive methods, as evidenced by this study.
本研究旨在展示在纽约市一家城市社区教学医院实施患者血液管理（PBM）计划如何有效减少不必要的红细胞（RBC）输血。
对2013年至2019年的七年进行分析，对红细胞输血进行回顾性研究。
引入PBM后，每年都观察到显著改善。这些改善包括输血前平均血红蛋白水平从2013年的7.26 g/dL降至2019年的6.58 g/dL，每年红细胞单位输血量减少34%，以及给予血红蛋白水平≥7 g/dL患者的单位数减少（从2013年的1210单位降至2019年的310单位）。此外，本研究指出，当血红蛋白水平≥7 g/dL时，两单位红细胞订单从2013年的65份降至2019年的仅3份。2014年全面实施后，为期六年的PBM计划估计节省的总成本达210万美元。
总体而言，实施PBM显著减少了红细胞输血并改善了输血实践。研究结果强调，成功的PBM策略并不总是需要大量资源或增加预算，而是依赖于直观方法的应用，本研究证明了这一点。
